Inventor · disambiguated record
Thomas F. Bumol
Also filed as: BUMOL THOMAS F · BUMOL THOMAS FRANK
8 granted patents·3 pending applications·355 citations·filing 1988–2022
90Inventor score
Top patents by PatentIndex Score
11 records- 0195US4975369ARecombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigenLILLY CO ELI·Filed 1988·Granted Dec 4, 1990·208 cites·77 claims
- 0279US5196324AMonoclonal antibodies reactive with a human atheroma associated antigenLILLY CO ELI·Filed 1990·Granted Mar 23, 1993·42 cites·4 claims
- 0370US5732717AMethod for treating substance abuse withdrawalLILLY CO ELI·Filed 1996·Granted Mar 31, 1998·28 cites·17 claims
- 0469US5597726AMonoclonal antibodies reactive with a human atheroma associated antigenLILLY CO ELI·Filed 1995·Granted Jan 28, 1997·16 cites·8 claims
- 0568US5574047AMethods of inhibiting imperfect tissue repairLILLY CO ELI·Filed 1993·Granted Nov 12, 1996·18 cites·5 claims
- 0660US5686467AMethods of inhibiting imperfect tissue repairLILLY CO ELI·Filed 1995·Granted Nov 11, 1997·13 cites·4 claims
- 0758US2025059608A1Molecular signatures for cell typing and monitoring immune healthALLEN INST·Filed 2022·Application pending·0 cites
- 0857US5348887AVectors and DNAS for expression of a human adenocarcinoma antigenLILLY CO ELI·Filed 1992·Granted Sep 20, 1994·18 cites·27 claims
- 0956US5580774AChimeric antibodies directed against a human glycoprotein antigenLILLY CO ELI·Filed 1989·Granted Dec 3, 1996·12 cites·36 claims
- 1049US2024219385A1Molecular signatures of long-term covid-19 and treatment thereofALLEN INST·Filed 2022·Application pending·0 cites
- 1141US2004167074A1Therapeutic applications of mFLINT polypeptidesFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas F. Bumol files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →